Hyperbaric Oxygen Therapy and Pain: What the Research Actually Shows

Pain that sticks around after the injury has healed is one of the most frustrating things a body can do to a person. The scan looks fine. The tissue closed up months ago. And yet the ache, the burning, the tenderness — it's all still there.

If you've been living with that, you've probably already worked your way through the usual list: physical therapy, anti-inflammatories, injections, maybe a specialist or three. And you may have come across hyperbaric oxygen therapy along the way and wondered whether it's worth your time.

Here's an honest look at what oxygen under pressure can and can't do for pain — the mechanisms that make it plausible, the studies that have actually been run, and the places where the evidence is still thin.

Why oxygen has anything to do with pain in the first place

Chronic pain isn't just a signaling problem. In a lot of cases there's a real, physical process underneath it: inflamed tissue, poor blood flow, swelling that compresses the very vessels meant to feed the area.

That creates a loop. Injury causes swelling. Swelling restricts circulation. Restricted circulation starves the tissue of oxygen. Oxygen-starved tissue can't complete repair, stays inflamed, and keeps firing pain signals — which is exactly the state researchers have documented in conditions like complex regional pain syndrome, where deep tissue hypoxia is a measurable feature.

Hyperbaric oxygen therapy interrupts that loop from two directions at once.

More oxygen reaches the tissue. Under pressure, oxygen dissolves directly into your blood plasma rather than relying on red blood cells to carry it. This matters because plasma reaches places crowded or inflamed tissue makes hard for red cells to get to. In full-pressure clinical protocols, dissolved oxygen in the blood rises many times over its normal resting level.

Swelling goes down. The increased pressure causes mild constriction of small arteries, which reduces fluid leakage into tissue — and because the oxygen content of the blood is so much higher, the tissue still gets more oxygen overall, not less. Less swelling, better delivery.

Underneath that, researchers have documented a set of secondary effects that are directly relevant to pain: HBOT appears to downregulate inflammatory messengers like TNF-α, calm activated microglia (the immune cells of the nervous system that help maintain neuropathic pain), and trigger a nitric-oxide-dependent release of the body's own opioid peptides. That last mechanism is well enough established that blocking the nitric oxide pathway in animal studies blocks HBOT's pain-relieving effect.

What the studies on hyperbaric oxygen therapy for pain found

Mechanisms are only interesting if the outcomes follow. Here's where things stand.

Fibromyalgia has the most data. A systematic review published in the Journal of Pain Research in March 2026 pulled together 11 randomized controlled trials covering 480 participants, eight of which studied fibromyalgia. Pain reductions in those trials clustered around 2 to 3 points on a 10-point scale — one study reported a mean decrease of 3.31 points, another 2.31 points with a statistically significant advantage over medication.

That's meaningful. But an earlier meta-analysis of four fibromyalgia RCTs found something more nuanced: pooled across studies, the effect on visual-analogue pain scores didn't reach statistical significance, while tender point counts and overall quality of life (measured by the Fibromyalgia Impact Questionnaire) both improved significantly. In other words, the benefits are real but uneven, and how you measure them changes the answer.

A lower-pressure protocol held up well. One trial worth singling out compared 40 sessions of low-pressure HBOT at 1.45 ATA against a supervised exercise program in 49 women with fibromyalgia. The HBOT group's pain scores dropped 2.47 points; the exercise group's dropped 0.75 and didn't reach significance. Fatigue improved in the HBOT group only. This is one study, not a body of evidence — but it's directly relevant, because hyperbaric pain research spans a wide pressure range (roughly 1.45 to 2.4 ATA across the trials in the 2026 review), and this one sat at the low end of it.

Nerve-related pain shows promise. Reviews of neuropathic pain report encouraging results for trigeminal neuralgia (including sustained reductions in medication dose), postherpetic neuralgia, and radiation-induced nerve injury. The complex regional pain syndrome literature is smaller — one randomized trial plus a scattering of case series — but consistently reports reduced pain, less swelling, and improved range of motion.

Recovery-related pain is the most intuitive fit. For post-surgical and post-injury soreness, the case rests on the same mechanisms that make HBOT useful for wound healing: less edema, better oxygen delivery to healing tissue, and support for new blood vessel formation.

What a real course looks like

The single most common mistake is expecting one session to do something. In nearly every trial that showed results, participants completed 40 sessions, five days a week, at 60 to 90 minutes each. A few protocols ran to 60 sessions. None of them found benefit from occasional visits.

If you're going to try this, try it properly — a consistent block of sessions, tracked against a specific outcome you care about, whether that's your pain score, your sleep, your medication use, or how far you can walk before it flares.

Thinking about it?

We're happy to talk it through with you, including whether we think it's a reasonable fit for your situation. If you're managing a chronic pain condition, bring your doctor into that conversation too.

Come see the chambers, ask us hard questions, and decide from there.

Book a session or reach out with questions — we'd rather you start informed than start uncertain.

This post is for educational purposes and isn't medical advice. Hyperbaric oxygen therapy is not FDA-cleared for the treatment of chronic pain. Please consult your physician about your specific condition, particularly if you have a history of lung disease, recent ear surgery, or untreated pneumothorax.